Atlas Trials

Clinical Study To Evaluate The Performance And Safety Of Favipiravir in COVID-19

Clinical trial NCT04336904 · UNKNOWN

Trial details

NCT number
NCT04336904
Sponsor
Giuliano Rizzardini
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
COVID-19
Start date
2020-03-25
Primary completion
2020-07-01
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.